欧盟制定了生物通用名药审批规范，而美国政策尚不明朗。
EU publishes Guidelines on similar biological medicinal products, while regulations are still not clear in United States.
其它的步骤包括提倡戒烟、锻炼和饮食调节，加之应用通用名药物来降低血压、控制血糖和胆固醇。
Other steps include the promotion of smoking cessation, exercise and diet programmes plus the use of generic drugs to reduce blood pressure, control blood sugar and cholesterol.
文中对于生物通用名药的政策法规、研发、产品现状进行综述，并对面临的挑战和发展趋势进行了分析。
This article overviewed biogeneric drug policies, regulations, research and development, product status quo, and also discussed its challenges and trends.
应用推荐